Aptima Neisseria gonorrhoeae Assay
FDA 510(k) K231329 · Hologic, Inc.
510(k) numberK231329
Submission
- Device name
- Aptima Neisseria gonorrhoeae Assay
- Applicant
- Hologic, Inc.
San Diego, CA, US - Received
- May 8, 2023
- Decision date
- January 26, 2024
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- LSL – Dna-Reagents, Neisseria
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3390
- Specialty
- Microbiology
Other 510(k)s with product code LSL
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K180681 | Aptima Combo 2 Assay (Panther System)LSL · Traditional | Hologic, Inc. | 06/13/2018SE |
| K173887 | cobas CT/NG for use on cobas 6800/8800 systemsLSL · Traditional | Roche Molecular Systems, Inc. | 03/21/2018SE |
| K173840 | Xpert CT/NGLSL · Traditional | Cepheid | 03/16/2018SE |
| K163184 | cobas® CT/NG v2.0 TestLSL · Traditional | Roche Molecular Systems, Inc. | 02/09/2017SE |
| K140448 | BD Probetec Neisseria Gonorrhoeae (GC) QX Amplified DNA AssayLSL · Traditional | Becton, Dickinson & CO | 05/20/2014SE |
| K140354 | Abbott Multi-Collect Specimen Collection Kit, Abbott Real Time Ct/NgLSL · Traditional | Abbott Molecular, Inc. | 05/09/2014SE |
| K140887 | Cobas Ct/Ng V2.0 TestLSL · Special | Roche Molecular Systems, Inc. | 05/05/2014SE |
| K132270 | Cobas Ct/Ng V2.0 TestLSL · Traditional | Roche Molecular Systems, Inc. | 12/02/2013SE |
| K132251 | Aptima Combo 2 Assay (Panther System)LSL · Traditional | Hologic / Gen-Probe Incorporated | 10/17/2013SE |
| K121710 | Xpert Ct/NgLSL · Traditional | Cepheid | 12/27/2012SE |
More from Cepheid
| 510(k) | Device | Decision |
|---|---|---|
| K254090 | I-View®MUE · Traditional | 09/02/2026SE |
| K262792 | Brevera Biopsy System with CorLumina Imaging Technology (BREVDISP09)KNW · Special | 08/12/2026SE |
| K253634 | CoolSeal Generator® (CSL-200-90)GEI · Traditional | 06/17/2026SE |
| K251993 | Panther Fusion GI Expanded Bacterial AssayPCH · Traditional | 09/25/2025SE |
| K251868 | Panther Fusion GI Bacterial AssayPCH · Traditional | 09/25/2025SE |
| K243341 | Genius AI Detection 2.0QDQ · Traditional | 07/31/2025SE |
| K243396 | Aptima SARS-CoV-2 AssayQQX · Traditional | 02/13/2025SE |
| K243935 | Aptima CMV Quant AssayPAB · Special | 01/17/2025SE |
| K243345 | Aptima BV Assay; Aptima CV/TV AssayPQA · Special | 11/25/2024SE |
| K242465 | Panther Fusion SARS-CoV-2/Flu A/B/RSV assayQOF · Traditional | 11/15/2024SE |
Questions and answers
When was Aptima Neisseria gonorrhoeae Assay cleared by the FDA?
Aptima Neisseria gonorrhoeae Assay (K231329) received a 510(k) decision of Substantially Equivalent on January 26, 2024, 263 days after the submission was received.
What is the product code of K231329?
The FDA product code is LSL – Dna-Reagents, Neisseria, a Class II (moderate risk) device regulated under 21 CFR 866.3390.